Metabolic Research
Retatrutide
Strength · 5mg
For research use onlyStrength
Price · Single vial (AUD)
$119
$65
AUDLimited research allocation
Pre-release pricing applied automatically at checkout
- AU-based fulfilment
- Discreet dispatch
- Tracking provided
- Secure checkout
Crypto settlement available at checkout.
Research Information
Compound profile
Neutral, scientific reference information provided for laboratory research contexts only.
Short Description
A triple GIP, GLP-1, and glucagon receptor agonist peptide studied in preclinical metabolic research.
Research Overview
Investigated in in vitro and preclinical models for triple incretin and glucagon receptor interactions.
Mechanism of Interest
Studied for simultaneous binding at the GIP, GLP-1, and glucagon class B G-protein-coupled receptors.
Key Research Areas
- Triple agonist receptor binding studies
- Comparative incretin pharmacology
- In vitro metabolic signalling assays
- Preclinical pharmacokinetic research
Compliance Notice
For research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.
Complete Your Research Set
Build a coordinated research set
Base Selection
Already selected
Common Research Pairing
Pre-selected
Extended Research Set
Optional
Selected Total
$135 AUD
For research use only. Items listed at standard AUD pricing — base product pricing is unchanged. Adjust the selection to suit your laboratory requirements.
Research Use Only. This product is supplied for laboratory research purposes only. Not intended for human or animal consumption, medical use, diagnostic use, therapeutic use, or performance enhancement.
Related research compounds
You may also research
Retatrutide
$65 AUD